- News
- Events
March 1-2, 2025
Piacenza, Italy
Giovanni Pacchiana
MICK® was pleased to take part in the 1st National Congress of MICS (Microbiota International Clinical Society), held in Piacenza, Italy. This inaugural event brought together healthcare professionals, researchers, and biotech innovators to explore how microbiome science can be effectively translated into clinical practice.
Our representative, Giovanni Pacchiana, attended the congress to connect with peers and discuss the integration of omics-based data into diagnostic and therapeutic workflows. Topics included the microbiome’s role in chronic diseases, gut-brain interactions, and the use of microbiota analysis in personalized healthcare.
The congress offered a valuable space for exchanging ideas and reinforcing our commitment to bridging the gap between research and patient-centered solutions.
SEQUENTIA® BIOTECH SL
Barcelona
+34 930 107 368
* Sending the email implies acceptance of the Privacy Policy.
MICK® is co-founded by the European Union - grant agreement 190195702
European Union Funding H2020 Research and Innovation programme - grant agreement #868117
MICK® does not claim to diagnose, treat, cure, or prevent any disease. The information on the MICK® website is provided for informational purposes only and with the understanding that MICK® is not engaged in rendering medical advice or recommendations. You should not rely on any information on the website to diagnose or treat a health problem or condition or replace consultations with qualified health care professionals to meet your individual needs. Always check with your doctor for answers to your personal medical questions.
Copyright © Sequentia® Biotech 2024
